The Role of Biomarkers in Parkinson’s Disease

FILTER CATEGORY

Translating a Parkinson’s disease (PD) diagnosis into diagnostic criteria used in clinical studies is often impossible. Moreover, PD diagnostic accuracy at first visit is only slightly above 80%. Such findings highlight the need for diagnostic tests and biomarkers to enhance diagnostic confidence in early disease, or to eventually diagnose PD in its prodromal stages.

Constructing Composites to Optimise Cognitive Outcomes

FILTER CATEGORY

The relative insensitivity of traditional cognitive outcome measures to describe more subtle and selective cognitive impairment has resulted in a recent boon in cognitive composite measures.
This article is taken from the Journal of Clinical Studies, Volume 9, Issue 2, by Henry J. Riordan, Ph.D.

At the Forefront of Drug Discovery and Development: Small to Midsize Biotech/Biopharma Companies are the Leaders of Innovation

FILTER CATEGORY

Today, the innovators of drug discovery and development are the smaller, biotech and biopharma companies around the world. According to a report from HBM Partners AG, in the past several years, more than 60% of new drugs approved originated at small and midsize companies – those outside the 30 largest pharmaceutical firms.
This article is taken from PharmaVoice, April 2017, by Peter Benton.